Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4a37bd61a634b42be8f0d3b63f3a30ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7c112a251c2ec3fd95773b38bdfbfd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4bc13571c32e3743850602a10f40b344 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-285 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate |
2009-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f85848f4d6f1c0d9a7c44e608ce85381 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5da28f2f48acbd1384896df36a79b12 |
publicationDate |
2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8216791-B2 |
titleOfInvention |
Method for diagnosing multiple sclerosis |
abstract |
Disclosed is a method for diagnosing and prognosing multiple sclerosis and more particularly to a method for diagnosing and prognosing multiple sclerosis by measuring levels of antibodies. The levels of IgM-type anti-Glc(α1,2)Glc(α) or Glc(α1,3)Glc(α) or Glc(α1,6)Glc(α) antibodies in serum act as diagnostic markers for MS disease and as prognostic biomarkers for the conversion of CIS patients suggestive of MS to clinically definite MS (CDMS) within 24 months. |
priorityDate |
2005-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |